Intellia Therapeutics (NASDAQ: NTLA) was lifted to Outperform from Market Perform by BMO Capital Markets analyst Kostas Biliouris on Monday ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Hot List Upgrades

BMO Capital Upgrades Intellia Therapeutics (NTLA) to Outperform, 'Risk/Reward Is Now Skewed to the Upside'March 13, 2023 4:05 PM Stifel Lays Out Biotech Names Exposure to SVB Financial Group (SIVB) March 10, 2023 1:12 PM